Celanese Corp: Form 10-K for the period ended Dec 31, 2016
Filed with the SEC on Feb 10, 2017 and accepted by EDGAR at Feb 10, 2017, 16:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2016-01-01 to 2016-12-31 | $3.98bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2016-01-01 to 2016-12-31 | $1.41bn | us-gaap:GrossProfit |
| Research and development | 12 months2016-01-01 to 2016-12-31 | $78.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2016-01-01 to 2016-12-31 | $416.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2016-01-01 to 2016-12-31 | $893.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2016-01-01 to 2016-12-31 | $120.0m | us-gaap:InterestExpense |
| Income tax | 12 months2016-01-01 to 2016-12-31 | $122.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2016-01-01 to 2016-12-31 | $900.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2016-01-01 to 2016-12-31 | $6.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2016-01-01 to 2016-12-31 | $6.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2016-01-01 to 2016-12-31 | 145,668,181 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2016-01-01 to 2016-12-31 | $893.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2016-01-01 to 2016-12-31 | $246.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2016-01-01 to 2016-12-31 | $201.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2016-01-01 to 2016-12-31 | $500.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-12-31 | $638.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-12-31 | $2.47bn | us-gaap:AssetsCurrent |
| Total assets | At period end2016-12-31 | $8.36bn | us-gaap:Assets |
| Current liabilities | At period end2016-12-31 | $1.08bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2016-12-31 | $2.89bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2016-12-31 | $118.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2016-12-31 | $2.59bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001306830-17-000034. Last ingested by Listed: Nov 13, 2026, 16:24 ET. Listed shows no prices and gives no investment advice.